A scientist hard at work


May 18th 2009: Novel technique developed at CHOP may lead to HIV vaccine
Contact:  Philip Johnson, M.D., 267-426-0351

April 16, 2006: Zambia Begins First Preventive HIV Vaccine Trial
LUSAKA, Zambia & SEATTLE--(BUSINESS WIRE) — April 26, 2006 — The Zambia Emory HIV Research Project (ZEHRP), the International AIDS Vaccine Initiative (IAVI) and Targeted Genetics Corporation (Nasdaq: TGEN - News) today announced the initiation of a clinical trial in Zambia to test the safety and immunogenicity of tgAAC09, a preventive HIV vaccine.
Contact:  Philip Johnson, M.D., 267-426-0351

August 30, 2006: Targeted Genetics:
Interim Data from Targeted Genetics' Phase I HIV/AIDS Vaccine Trial to Be
Presented at Leading European AIDS Vaccine Meeting; Vaccine Candidate Well
Tolerated; Modest Immune Response Observed in a Subset of Patients